XML 36 R19.htm IDEA: XBRL DOCUMENT
v3.20.4

Shareholders' Equity and Other Comprehensive Income | 12 Months Ended
--- | ---
Dec. 31, 2019
Stockholders' Equity Note [Abstract] |
Shareholders' Equity and Other Comprehensive Income | Note 11 - Shareholders' Equity and Other Comprehensive Income The following table shows the changes in shares of preferred and common stock issued and common stock held as treasury shares for the years ended December 31, 2020, 2019, and 2018.
(shares in thousands) | Series C Preferred Stock Issued (Redeemed) |  | Series D Preferred Stock Issued |  | Series E Preferred Stock Issued |  | Total Preferred Stock Issued (Redeemed) |  | Common Stock Issued |  | Treasury Stock Held |  | Common Stock Outstanding
Balance at December 31, 2017 | 5,200 |  |  | — |  |  | — |  |  | 5,200 |  |  | 142,678 |  |  | 23,781 |  |  | 118,897 |
Issuance of preferred stock | — |  |  | 8,000 |  |  | — |  |  | 8,000 |  |  | — |  |  | — |  |  | — |
Redemption of preferred stock | (5,200) |  |  | — |  |  | — |  |  | (5,200) |  |  | — |  |  | — |  |  | — |
Issuance of common stock for earnout payment | — |  |  | — |  |  | — |  |  | — |  |  | 199 |  |  | — |  |  | 199 |
Restricted share unit activity | — |  |  | — |  |  | — |  |  | — |  |  | 297 |  |  | — |  |  | 297 |
Stock options exercised | — |  |  | — |  |  | — |  |  | — |  |  | 126 |  |  | — |  |  | 126 |
Repurchase of common stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 3,653 |  |  | (3,653) |
Balance at December 31, 2018 | — |  |  | 8,000 |  |  | — |  |  | 8,000 |  |  | 143,300 |  |  | 27,434 |  |  | 115,866 |
FCB acquisition: |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock for acquisition | — |  |  | — |  |  | — |  |  | — |  |  | 22,043 |  |  | — |  |  | 22,043 |
Common stock reissued | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (27,434) |  |  | 27,434 |
Warrants exercised and common stock reissued | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (260) |  |  | 260 |
Issuance of preferred stock | — |  |  | — |  |  | 14,000 |  |  | 14,000 |  |  | — |  |  | — |  |  | — |
Issuance of common stock for earnout payment | — |  |  | — |  |  | — |  |  | — |  |  | 344 |  |  | — |  |  | 344 |
Restricted share unit activity | — |  |  | — |  |  | — |  |  | — |  |  | 302 |  |  | — |  |  | 302 |
Stock options exercised | — |  |  | — |  |  | — |  |  | — |  |  | 812 |  |  | — |  |  | 812 |
Repurchase of common stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 19,903 |  |  | (19,903) |
Balance at December 31, 2019 | — |  |  | 8,000 |  |  | 14,000 |  |  | 22,000 |  |  | 166,801 |  |  | 19,643 |  |  | 147,158 |
Issuance of common stock for earnout payment | — |  |  | — |  |  | — |  |  | — |  |  | 379 |  |  | — |  |  | 379 |
Restricted share unit activity | — |  |  | — |  |  | — |  |  | — |  |  | 389 |  |  | — |  |  | 389 |
Stock options exercised | — |  |  | — |  |  | — |  |  | — |  |  | 564 |  |  | — |  |  | 564 |
Repurchase of common stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 450 |  |  | (450) |
Balance at December 31, 2020 | — |  |  | 8,000 |  |  | 14,000 |  |  | 22,000 |  |  | 168,133 |  |  | 20,093 |  |  | 148,040 |
Preferred Stock Issuance of Series E Preferred Stock On July 1, 2019, Synovus completed a $350.0 million public offering of Series E Preferred Stock. The offering generated net proceeds of $342.0 million. Dividends on the shares are non-cumulative and, if declared, will accrue and be payable, in arrears, quarterly at a rate per annum equal to 5.875% for each dividend period from the original issue date to, but excluding, July 1, 2024. From and including July 1, 2024, the dividend rate will change and reset every five years on July 1 at a rate equal to the five-year U.S. Treasury Rate plus 4.127% per annum. The Series E Preferred Stock is redeemable at Synovus' option in whole or in part, from time to time, on July 1, 2024 or any subsequent reset date, or in whole but not in part, at any time within 90 days following a regulatory capital treatment event, in each case, at a redemption price equal to $25 per share, plus any declared and unpaid dividends, without accumulation of any undeclared dividends. The Series E Preferred Stock has no preemptive or conversion rights. Except in limited circumstances, the Series E Preferred Stock does not have any voting rights. Issuance of Series D Preferred Stock On June 21, 2018, Synovus completed a $200.0 million public offering of Series D Preferred Stock, $25 per share liquidation preference. The offering generated net proceeds of $195.1 million. Dividends on the shares are non-cumulative and, if declared, will accrue and be payable, in arrears, quarterly at a rate per annum equal to 6.300% for each dividend period from the original issue date to, but excluding, June 21, 2023. From and including June 21, 2023, the dividend rate will change to a floating rate equal to the three-month LIBOR plus a spread of 3.352% per annum. The Series D Preferred Stock is redeemable at Synovus' option in whole or in part, from time to time, on any dividend payment date on or after June 21, 2023, or in whole, but not in part, at any time within 90 days following a regulatory capital treatment event at a redemption price equal to $25 per share, plus any declared and unpaid dividends, without accumulation of any undeclared dividends. The Series D Preferred Stock has no preemptive or conversion rights. Except in limited circumstances, the Series D Preferred Stock does not have any voting rights. Redemption of Series C Preferred Stock On August 1, 2018, Synovus redeemed all 5,200,000 outstanding shares of Series C Preferred Stock for a cash price of $25 per share, without interest, for an aggregate redemption price of $130.0 million and paid a dividend of $2.6 million on the Series C Preferred Stock. Concurrent with the redemption, Synovus recognized a one-time, non-cash redemption charge of $4.0 million. Common Stock Stock issued for acquisition of FCB On January 1, 2019, as part of the FCB acquisition, Synovus issued 22.0 million shares of common stock and reissued 27.4 million shares of treasury stock. The total value of the acquisition consideration transferred by Synovus, including exchanged equity awards and warrants, was $1.63 billion. See "Part II - Item 8. Financial Statements and Supplementary Data - Note 2 - Acquisitions" in this Report for more information on the FCB acquisition. Stock issued related to acquisition of Global One On October 1, 2016, Synovus completed its acquisition of all of the outstanding stock of Global One. Under the terms of the merger agreement, the purchase price included additional annual payments to Global One's former shareholders over a period not to extend beyond June 30, 2021, with amounts based on a percentage of Global One earnings as defined in the merger agreement. The earnout payments consist of shares of Synovus common stock as well as a smaller cash consideration component. Annual earnout payments made during 2018, 2019, and 2020, included 199 thousand, 344 thousand, and 379 thousand shares, respectively, of Synovus common stock valued at $7.4 million, $11.8 million, and $8.7 million, respectively. Repurchases of Common Stock During the first quarter of 2020, Synovus repurchased $16.2 million, or 450 thousand shares, of common stock through open market transactions under the share repurchase program announced on January 24, 2020. During 2019, Synovus repurchased $725.0 million, or 19.9 million shares, of common stock through open market transactions under the $725.0 million share repurchase program, with $400.0 million authorized during the fourth quarter of 2018 for execution in 2019 and $325.0 million authorized in 2019. During 2018, Synovus repurchased $175.0 million, or 3.7 million shares, of common stock through open market transactions under the $150.0 million and $25.0 million share repurchase programs authorized during the fourth quarter of 2017 and the fourth quarter of 2018, respectively, for execution during 2018. Warrants In connection with the acquisition of FCB on January 1, 2019, outstanding FCB warrants were converted into 913 thousand warrants to purchase shares of Synovus common stock. At December 31, 2019, all warrants had been exercised, converting into 263 thousand shares of Synovus common. Accumulated Other Comprehensive Income (Loss) The following table illustrates activity within the balances in AOCI by component, and is shown for the years ended December 31, 2020, 2019, and 2018.
Changes in Accumulated Other Comprehensive Income (Loss) by Component (Net of Income Taxes)
(in thousands) | Net Unrealized Gains (Losses) on Investment Securities Available for Sale(1) |  | Net Unrealized Gains (Losses) on Cash Flow Hedges(1) |  | Post-Retirement Unfunded Health Benefit |  | Total
Balance at December 31, 2017 | $ | (43,470) |  |  | $ | (12,137) |  |  | $ | 853 |  |  | $ | (54,754) |
Other comprehensive loss before reclassifications | (33,023) |  |  | — |  |  | (34) |  |  | (33,057) |
Amounts reclassified from accumulated other comprehensive income (loss) | 960 |  |  | — |  |  | (98) |  |  | 862 |
Net current period other comprehensive income (loss) | (32,063) |  |  | — |  |  | (132) |  |  | (32,195) |
Reclassification from adoption of ASU 2018-02 | (7,763) |  |  | — |  |  | 175 |  |  | (7,588) |
Cumulative-effect adjustment from adoption of ASU 2016-01 | 117 |  |  | — |  |  | — |  |  | 117 |
Balance at December 31, 2018 | $ | (83,179) |  |  | $ | (12,137) |  |  | $ | 896 |  |  | $ | (94,420) |
Other comprehensive income (loss) before reclassifications | 161,170 |  |  | (6,350) |  |  | (378) |  |  | 154,442 |
Amounts reclassified from accumulated other comprehensive income (loss) | 5,675 |  |  | — |  |  | (56) |  |  | 5,619 |
Net current period other comprehensive income (loss) | 166,845 |  |  | (6,350) |  |  | (434) |  |  | 160,061 |
Balance at December 31, 2019 | $ | 83,666 |  |  | $ | (18,487) |  |  | $ | 462 |  |  | $ | 65,641 |
Other comprehensive income (loss) before reclassifications | 80,491 |  |  | 73,502 |  |  | — |  |  | 153,993 |
Amounts reclassified from accumulated other comprehensive income (loss) | (58,488) |  |  | (2,049) |  |  | (462) |  |  | (60,999) |
Net current period other comprehensive income (loss) | 22,003 |  |  | 71,453 |  |  | (462) |  |  | 92,994 |
Balance at December 31, 2020 | $ | 105,669 |  |  | $ | 52,966 |  |  | $ | — |  |  | $ | 158,635 |
(1) For all periods presented, the ending balance in net unrealized gains (losses) on investment securities available for sale and cash flow hedges includes unrealized losses of $13.3 million and $12.1 million, respectively, related to residual tax effects remaining in OCI due to previously established deferred tax asset valuation allowances in 2010 and 2011. In accordance with ASC 740-20-45-11(b), under the portfolio approach, these unrealized losses are realized at the time the entire portfolio is sold or disposed.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration